pcn poster

Posters

The Association Between Depression Severity and Social Stigma in Undergraduate Students

This poster was presented at the 30th annual  Psych Congress, held Sept. 16-19, 2017, in New Orleans, Louisiana.

12/21/2017

Symptoms Targeted for Treatment by Caregivers of People With Dementia and Agitation

This poster was presented at the 30th annual  Psych Congress, held Sept. 16-19, 2017, in New Orleans, Louisiana. Background: Neuropsychiatric symptoms (NPS) are associated with a wo...

12/21/2017

Symptom Burden Among Self-Reported ADHD Adults in the United States

This poster was presented at the 30th annual  Psych Congress, held Sept. 16-19, 2017, in New Orleans, Louisiana. Introduction: Evaluating attention-deficit hyperactivity disorder (A...

12/21/2017

Switching Patients With Schizophrenia From Paliperidone Palmitate to Aripiprazole Lauroxil: A 6-month, Prospective Open-label Study

This poster was presented at the 30th annual  Psych Congress, held Sept. 16-19, 2017, in New Orleans, Louisiana. Background: Despite the growing number of long-acting antipsychotic ...

12/21/2017

Serendipitous Improvement of Schizophrenia After Triple Bone Marrow Stem Cell Transplant for Cancer: A Case Report

This poster was presented at the 30th annual  Psych Congress, held Sept. 16-19, 2017, in New Orleans, Louisiana.

12/21/2017

Self-Reported Life Problems Associated With Cannabis Use Among Adults Enrolled in a Cannabis Use Disorder Pharmacotherapy Trial

This poster was presented at the 30th annual  Psych Congress, held Sept. 16-19, 2017, in New Orleans, Louisiana.

12/21/2017

Safety and Pharmacokinetic Profile of a 2-Month Dose Regimen of Aripiprazole Lauroxil: A 44-Week Phase 1 Study and Subsequent Population Pharmacokinetic Modeling

This poster was presented at the 30th annual  Psych Congress, held Sept. 16-19, 2017, in New Orleans, Louisiana. Introduction: Aripiprazole lauroxil (AL) is an FDA-approved, long-ac...

12/21/2017

Responder Classification of Patients Engaged With a Digital Medicine System Based on Data Quality Footprints

This poster was presented at the 30th annual  Psych Congress, held Sept. 16-19, 2017, in New Orleans, Louisiana. The convergence of technology and traditional pharmaceutical-based t...

12/21/2017

Relapse Prevention With Levomilnacipran ER in Adults With Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study

This poster was presented at the 30th annual  Psych Congress, held Sept. 16-19, 2017, in New Orleans, Louisiana. Introduction: Levomilnacipran extended-release (LVM-ER) is a seroton...

12/21/2017

Rank Association With PTSD Severity in a U.S. Active Duty Military Inpatient Population

This poster was presented at the 30th annual  Psych Congress, held Sept. 16-19, 2017, in New Orleans, Louisiana. Background: The military's ranks are filled with a wide variety of m...

12/21/2017

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

Rapid Refresh

Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics

04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...

Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...

Andrew Penn, MS, PMHNP, and...

04/11/2024

Psych Congress NP Institute

Rapid Refresh

Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder

04/10/2024

Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...

Amber Hoberg, PMHNP-BC,...

04/10/2024

Psych Congress NP Institute

Clinical Pearls

Tolerability Testing in Long-Acting Injectable Prescriptions

04/03/2024

Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.

Posters

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

Sign Up

Specialties

Events

Year Round Education

HMP Global Products